Type to search

Swissmedic Authorizes Moderna’s Omicron-targeting Bivalent Booster Candidate, mRNA-1273.214 | Pharmtech Focus
Arpa Garay Joins Moderna as Chief Commercial Officer | Pharmtech Focus